Long-term treatment of Parkinson's disease with bromocriptine.

BRomocriptine (15-75 mg per day) alone or with L-dopa was studied during five to 29 months on 44 patients with Parkinson's disease. Used as sole therapeutic agent, it was found excellent in 12 patients who had never received regular L-dopa treatment either because it was never attempted or because o...

ver descrição completa

Detalhes bibliográficos

Publicado no:	J Neurol Neurosurg Psychiatry
Principais autores:	Rascol, A, Guiraud, B, Montastruc, J L, David, J, Clanet, M
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMJ Publishing Group 1979
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC490179/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/422961/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/jnnp.42.2.143
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!